Neurocrine Biosciences, Inc. (NBIX)
NASDAQ: NBIX · IEX Real-Time Price · USD
146.21
+2.07 (1.44%)
Jul 22, 2024, 10:17 AM EDT - Market open
Neurocrine Biosciences Analyst Ratings
Total Analysts
23
Consensus Rating
Buy
Price Target
$156.45
Upside
+7.00%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $160 → $170 | Buy | Maintains | $160 → $170 | +16.27% | Jul 12, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $169 → $173 | Buy | Maintains | $169 → $173 | +18.32% | Jul 10, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $160 | Buy | Maintains | $160 | +9.43% | Jun 12, 2024 |
| Wedbush | Wedbush | Buy Reiterates $152 | Buy | Reiterates | $152 | +3.96% | May 29, 2024 |
| UBS | UBS | Strong Buy Maintains $174 → $193 | Strong Buy | Maintains | $174 → $193 | +32.00% | May 28, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy Initiates $175 | Buy | Initiates | $175 | +19.69% | May 14, 2024 |
| Citigroup | Citigroup | Hold Maintains $140 → $150 | Hold | Maintains | $140 → $150 | +2.59% | May 3, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $154 → $164 | Strong Buy | Maintains | $154 → $164 | +12.17% | May 2, 2024 |
| Guggenheim | Guggenheim | Strong Buy Maintains $164 → $170 | Strong Buy | Maintains | $164 → $170 | +16.27% | May 2, 2024 |
| Barclays | Barclays | Buy Maintains $150 → $169 | Buy | Maintains | $150 → $169 | +15.59% | May 2, 2024 |
| BMO Capital | BMO Capital | Hold Maintains $129 → $138 | Hold | Maintains | $129 → $138 | -5.62% | May 2, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $200 → $216 | Buy | Maintains | $200 → $216 | +47.73% | May 2, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $150 → $160 | Strong Buy | Maintains | $150 → $160 | +9.43% | May 2, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 2, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 1, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $150 | Strong Buy | Reiterates | $150 | +2.59% | Apr 24, 2024 |
| Wells Fargo | Wells Fargo | Hold → Buy Upgrades $140 → $170 | Hold → Buy | Upgrades | $140 → $170 | +16.27% | Apr 24, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $200 | Buy | Maintains | $200 | +36.79% | Apr 24, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Apr 23, 2024 |
| Wedbush | Wedbush | Buy Reiterates $147 | Buy | Reiterates | $147 | +0.54% | Apr 17, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $155 | Buy | Reiterates | $155 | +6.01% | Apr 10, 2024 |